Why Slater & Gordon Limited deserves a place in your portfolio

Slater & Gordon Limited (ASX:SGH) is scoring plenty of runs in the Old Dart.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Slater & Gordon Limited (ASX: SGH) is to signal its UK presence in a big way with the recent leasing of a 7-storey office building in Manchester. The premises will house in excess of 700 staff and is the firm's largest office anywhere in the world. In pretty much a first the ground floor will include an area 'where members of the local community can just drop in, talk to a lawyer over a coffee and access legal information and resources in an approachable and relaxing environment.' The firm also has offices in London and Liverpool.

With the UK market five times the size of Australia, Slater & Gordon is well on the way to achieving similar revenues and margins to those in Australia within the next three years. Although they brought us SpecSavers the Brits aren't quite as familiar with dancing barristers and solicitors, and the active marketing campaign is making waves.

At present the three leading consumer law firms in the UK are Slater & Gordon, Irwin Mitchell and Minster Law – in addition the giant U.S. firm Jacoby & Meyer is making tentative moves into the market. However Slater & Gordon has now built substantial scale and acquisitions which are consolidating nicely. With the platform set for further strong growth, S&G is no longer knocking on the door; and now has 5%+ of the UK market.

In Australia Slater & Gordon has 25% of the personal injury market and continues to develop two other divisions – Personal Legal Services (conveyancing, family law, wills, probate etc) and Business & Specialised Litigation (commercial, professional negligence litigation, class actions and criminal defence work). Steady growth is expected from these divisions.

However 2015 onwards will demonstrate the benefits of the move into the UK. With the bedding down of acquisitions, 2015 earnings per share are estimated to increase to 34c and dividends to 10c – placing Slater & Gordon ($4.88) on forward ratios of 14.35 times earnings and a franked dividend of 2%. With a low PEG ratio (price earnings ratio ÷ projected growth rate in earnings) and solid prospects, Slater & Gordon is well placed to reward its investors.

Motley Fool contributor Peter Andersen owns shares in Slater & Gordon

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »